Invention Grant
US08927572B2 Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof 有权
二肽基肽酶-IV抑制剂盐的晶型I及其制备方法和用途

  • Patent Title: Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof
  • Patent Title (中): 二肽基肽酶-IV抑制剂盐的晶型I及其制备方法和用途
  • Application No.: US14127824
    Application Date: 2012-07-06
  • Publication No.: US08927572B2
    Publication Date: 2015-01-06
  • Inventor: Chutian Su
  • Applicant: Chutian Su
  • Applicant Address: CN Shandong
  • Assignee: Xuanzhu Pharma Co., Ltd.
  • Current Assignee: Xuanzhu Pharma Co., Ltd.
  • Current Assignee Address: CN Shandong
  • Agency: Cesari and McKenna, LLP
  • Agent Y. Rocky Tsao
  • Priority: CN201110202157 20110709
  • International Application: PCT/CN2012/078294 WO 20120706
  • International Announcement: WO2013/007167 WO 20130117
  • Main IPC: C07D401/14
  • IPC: C07D401/14 A61K31/444 C07D471/04
Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof
Abstract:
The present invention relates to the crystal form I of salt of a dipeptidyl peptidase-IV inhibitor, and the preparation method and use thereof. In particular, it relates to the crystal form I of dihydrochloride salt of the compound (R)-2-[[7-(3-aminopiperidin-1-yl)-3,5-dimethyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile represented by formula (1), which is a dipeptidyl peptidase-IV inhibitor, and the preparation method and use thereof. The crystal form I of dihydrochloride salt of the dipeptidyl peptidase-IV inhibitor represented by formula (1) is characterized in that it has characteristic peaks at 8.7±0.2°, 19.4±0.2°, 23.5±0.2° and 27.2±0.2° in X-ray powder diffraction indicated by an angle 2θ (°) using Cu—Kα irradiation.
Information query
Patent Agency Ranking
0/0